Clinical trial
A Phase II RCT of Topical Menthol Gel Versus Placebo in the Treatment of Chemotherapy Induced Peripheral Neuropathic Pain
NCT04276727 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II RCT of Topical Menthol Gel Versus Placebo in the Treatment of Chemotherapy Induced Peripheral Neuropathic Pain
- Lead sponsor
- University of Edinburgh
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 4, 2019
- Completion date
- March 24, 2022
- Enrollment
- 52 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapy-induced peripheral neuropathy